Screener
Kestra Medical Technologies KMTS Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Kestra Medical Technologies in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The source filing: Kestra Medical Technologies’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 5:16 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001193125-26-303397
| Line item | April 30, 2026 | April 30, 2025 |
|---|---|---|
| Disposable medical equipment supplies | 6,706 | 6,572 |
| Prepaid expenses and other current assets | 4,677 | 3,080 |
| Total current assets | 222,359 | 255,328 |
| Long-term investments | 65,767 | — |
| Right-of-use assets | 3,364 | 2,078 |
| Deposits | 1,761 | 2,021 |
| Restricted cash | 334 | 334 |
| Property and equipment, net | 59,090 | 34,830 |
Item 16. Form 10-K Summary.
FAQ
- What is Kestra Medical Technologies's equity method investments?
- Kestra Medical Technologies (KMTS) reported equity method investments of $65.77M in Q1 2026.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Kestra Medical Technologies's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude